CAMP4 Therapeutics
Cambridge, Massachusetts, United StatesFounded 201665+ employeesCAMP
$270M raisedGrowth· last: post ipo equity (Dec 2025)· 6 rounds
Backed by(16 investors)
Coastlands Capital · Lead5AM Ventures · LeadAndreessen Horowitz · LeadBiogen · LeadEnavate Sciences · LeadNorthpond Ventures · Lead+7 more
At CAMP4 Therapeutics, we are pioneering a novel approach to programmable therapeutics. We combine a deep understanding of regulatory RNA and gene expression with a complementary and customizable oligonucleotide modality. Our platform’s proprietary insights enable us to harness the power of RNA to upregulate the expression of genes and unlock the potential to create treatments for hundreds of diseases affecting millions of patients. Join us at the forefront.
